Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
Castellano, Daniel, González-Larriba, José L, Antón-Aparicio, Luis M, Cassinello, Javier, Grande, Enrique, Esteban, Emilio, Sepúlveda, JuanVolume:
12
Langue:
english
Journal:
Expert Opinion on Pharmacotherapy
DOI:
10.1517/14656566.2011.590132
Date:
November, 2011
Fichier:
PDF, 411 KB
english, 2011